A Precision Refinement with Big Pharmacy
Behalf of Precision Diagnostics (PD), this year, 2024, started to elevate our partner services with Big Pharmacy for unmatched Product Excellence, featuring our PRECISE Pharmacogenomics (PGx). We have also released one of our new products, PRECISE Nutrigenomics (NGx) which is currently available. In recent months, we have cultivated strategic partnerships with industry leaders to seamlessly integrate superior services with our cutting-edge products. These collaborations aim to exceed expectations and provide an unparalleled experience to our esteemed clients.
Our dedicated team has been working diligently to refine partner services, ensuring they align seamlessly with the unique attributes of our products, including, Dr. Rebecca Tay, Chief Executive Owner of Beacon Precision Diagnostics, who conducted, participated, and assisted in sharing the knowledge behind Pharmacogenomics (PGx). It is vital to be aware of how Pharmacogenomics can be implemented in our daily lives meanwhile adjourning to Nutrigenomics (NGx) emphasizes the study of the effects of nutrients on the expression of an individual’s genetic makeup.
We also provided monthly sessions in Chinese and English to clarify and introduce some of our services and products. The following sessions is vital, especially to introduce our services and ensure that most patients or clients know the benefits of Pharmacogenomics.
About BIG Pharmacy
BIG Pharmacy is one of Malaysia’s leading pharmacy chains, providing accessible healthcare services, prescription medications, health supplements and wellness products to support healthier communities.
About Precision Diagnostics
Precision Diagnostics is a precision medicine and genomic diagnostics organisation committed to translating advances in genomics into clinically meaningful healthcare solutions supported by clinical governance. Through its work in pharmacogenomics, precision oncology, genomic testing, clinical implementation, and international scientific collaboration, Precision Diagnostics aims to support safer, more personalised, and evidence-based patient care across Malaysia and the Asia-Pacific region.
